Lantheus Holdings, Inc.(LNTH)

Description: Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.

---

Keywords: Medicine Chemical Elements Disease Medical Imaging Prostate Cancer Medical Physics Heart Failure Stroke Post Transition Metals Gallium Artery Radiopharmaceuticals Coronary Artery Disease Artery Disease Congestive Heart Failure Perfusion Medicinal Radiochemistry Peripheral Vascular Disease Imaging Agent Neuron Perfusion Scanning Cardiovascular And Other Diseases Myocardial Perfusion Imaging

---

Home Page: www.lantheus.com

LNTH Technical Analysis

331 Treble Cove Road
North Billerica, MA 01862
United States
Phone: 978 671 8001

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)